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The Gut Microbiota and its Influence in Obesity
Introduction
The Gut Microbiota (GM) is similar among people, but everyone has a different composition.
Generally there is a relationship between the lost of microbial diversity and some diseases; this
alteration is known as dysbiosis, which has been described for many diseases, such as obesity.
Obesity, which currently is an enormous public health problem, is a consequence of alterations in
eating behaviour and how the body regulates energy intake, expenditure and storage. Recent
evidence suggest that the GM may play a role in obesity.
Figure 1. Filums most represented in
GM in a healthy and obese adult.
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Gut Microbiota and its Composition
Microbiota: microorganisms which live in the body.
Microbioma: collective of microbiota genomes.
About 1013-1014 microorganisms inhabit the human gut,
which represents 10 fold the number of eukaryotic cells
in the body.
It includes Bacteria, Archaea, Fungi and viruses (Fig.1).
Results
Probiotic Health Benefit
Lactobacillus gasseri SBT2055 
It reduces total mesenteric and subcutaneous adipose tissue masses.
There is also a reduction in the total HDL- cholesterol in serum.
Lactobacillus sakei NR28 It reduces significantly total body weight.
Lactobacillus rhamnosus GG The reduction is only  important in epididymial fat.
Bifidobacterium animalis
subsp. lactis BB-12 
It only has health benefit when administered with oligofructose
prebiotic.
Studies claim that an increase in the ratio Firmicutes/Bacteroidetes is directly related to obesity, however other authors have failed in demonstrate that. So, it is thought that the
differences in the GM composition are probably less important than the aspects based on the methagenomic functionality.
A dysbiosis could be caused by the diet, but there are other factors implicated. It is known that dysbiosis could promote the obesity through different mechanisms.
There are many studies of probiotics that confirm their effectiveness in obesity. Nevertheless, there are some issues at debate, for example the low probability of probiotic to survive the
journey until the intestines and the difficulty to colonize the gut surface. However some are able to replicate and persist in the gut temporarily, they disappear after stopping using them.
Conclusions
Methodology:
• MOOC course “Gut Check: Exploring Your Microbiome” by University of
Colorado
• Congress “SCI sobre Microbiota i Sistema Immunitari de la Mucosa 2014”
• Systematic literature search in PubMed database (selected publications in the
last five years)
The Influence of Diet on Gut Microbiota
A diet based on meat has more impact on the structure and functionality of GM
than a diet based on vegetables.
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Functions of the Gut Microbiota
SCFAs:
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The short-chain fatty acids (SCFAs) play 
an important role in host nutrition and 
energy homeostasis, controlling energy 
production, and storages as well as 
appetite.
o Protective
o Metabolic
o Trophic
Probiotics as an Obesity 
Treatment
Probiotics (WHO): “live microorganisms which when administered
in adequate amounts confer a health benefit on the host”
Linking the Gut Microbiota to Obesity
A high fat diet is associated with a chronic low-level inflammation and also alters the GM.
There are some changes in the obese GM and in some molecules related to the lean:
↑ Archaea (methanogens)
↓ Functional diversity in 
microbiome
↑ Microbial fermentation and 
extraction of energy from nutrients
↑LPS ↑Cytokines proinflammatory
↑adipogenesis
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↑Fat storage
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↑ SCFA
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↑ Gut 
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↓ AMPK ↓ Oxidation of fatty acids ↑adipogenesis
LPL uptakes the fatty fats from lipoproteins and accumulates the triglycerides in adipocytes.
Fiaf is a LPL inhibitor, whose expression is selectively suppressed by microbiota. This is a
reason why wild-type (wt) mice accumulate more fat than Germ free (GF) (Fig. 2).
AMPK: 5' adenosine monophosphate-activated protein kinase, LPL: lipoprotein lipase
Fiaf Fasting Induced Adipocyte Factor, LPS: lipopolisacarid
GF mice are sheltered from 
diet induced obesity.
Figure 2. Changes in a wt mice
when there is a GM transplant.
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Goals:
Describe the GM 
Relate the GM with obesity
Evaluate the probiotic treatment for obesity
